Meeting Program

13:00–13:15 Opening and welcome

13:15–14:15 Session 1: Diagnosis, Classification and Risk Assessment in 2026

14:15–15:15 Oral Abstract Session 1

15:15–15:30 Coffee break

15:30–16:30 Session 2: Future Diagnostic Platforms and Educational Needs – Data Overload

16:30–17:15 Debate: Frailty – When the patient is not eligible for any treatment

17:15–17:30 Coffee break

17:30–18:15 Satellite symposium 1

18:15–19:15 Welcome Reception + Poster session

08:00–08:45 Meet the Experts Breakfast

09:00–10:00 Session 3: Genomics in MPN, MDS, AML

10:00–11:00 Session 4: Microenvironment, proteomics, and microbiome

11:00–11:15 Coffee break

11:15–12:15 Session 5: Immunome in MPN, MDS and AML – What Is It and How to Target?

12:15–13:30 Lunch break

13:00–13:45 Satellite Symposium 3

13:45–14:45 Session 6: Treatment of MPN in 2026

14:45–15:00 Coffee break

15:00–16:00 Session 7: Treatment of MDS in 2026

16:00–16:45 Debate: Immunotherapy in MDS, a finished story?

16:45–17:00 Coffee break

17:00–17:45 Satellite Symposium 2

09:00–10:00 Session 8: Treatment of AML in 2026

10:00–11:00 Oral Abstract Session 2

11:00–11:15 Coffee break

11:15–12:00 Session 9: Challenging Clinical Cases

12:00–12:15 Closing ceremony

12:15–13:00 Farewell lunch